Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

Under-Use Of Hospice Care By Many Terminally Ill Patients: Study
Hospice, a well-established approach to palliative care, has enabled countless people worldwide to die with dignity. Through focusing on the patient rather than the disease, individuals can spend the last weeks of their lives in an environment where hospice caregivers minimize their pain, maximize their comfort, and provide bereavement services for loved ones and family members.
generic viagra online
ImmunoCellular Therapeutics Reports Additional Data From Promising Brain Cancer Clinical Trial
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) (IMUC), a biotechnology company, presented promising clinical data from a Phase I trial evaluating ICT-107, the company"s dendritic cell-based cancer vaccine product candidate for the treatment of glioblastoma. These data were reported at the American Society of Clinical Oncology Meeting in Orlando, Florida (Abstract #2032), and supplement the preliminary data from the completed clinical trial that the Company reported in December 2008.
News of the day
The Quality And Purity Of Retacrit(R) Was Readily Demonstrated And Was Shown To Maintain Haemoglobin Levels In Patients With Chronic Kidney Disease
Hospira Inc. (NYSE: HSP) presented two posters at the World Congress of Nephrology reporting new data and analysis on epoetin zeta (Retacrit®), its biosimilar epoetin.
Public Health

Aspirin And Secondary Prevention In Peripheral Artery Disease - A Perspective For The Early 21st Century

Mary McGrae McDermott, M.D., of the Northwestern University Feinberg School of Medicine, Chicago, and a contributing editor of JAMA, and Michael H. Criqui, M.D., M.P.H., of the University of California, San Diego School of Medicine, write that more research is needed regarding the outcomes of aspirin use by patients with PAD. "The meta-analysis by Berger et al enriches current understanding of the association of aspirin with cardiovascular outcomes in patients with PAD. However, based on the limitations of data available, the findings should not alter recommendations for aspirin as an important therapeutic tool for secondary prevention in patients with PAD. To best inform evidence-based clinical practice guidelines, more high-quality clinical trials are needed. Achieving this will require greater res for research and a larger critical mass of clinical investigators dedicated to the study of PAD." JAMA. 2009;301[18]:1927-1928. Journal of the American Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009